High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma

Holly Stessman, A. Lulla, T. Xia, A. Mitra, T. Harding, A. Mansoor, C. L. Myers, B. G. Van Ness, N. G. Dolloff

Research output: Contribution to journalLetter

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2263-2267
Number of pages5
JournalLeukemia
Volume28
Issue number11
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Neoplasm Drug Resistance
Boronic Acids
High-Throughput Screening Assays
Cultured Tumor Cells
Pyrazines
Preclinical Drug Evaluations
Proteasome Inhibitors
Enzyme Inhibitors
Proteasome Endopeptidase Complex
Multiple Myeloma
Antineoplastic Agents

All Science Journal Classification (ASJC) codes

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma. / Stessman, Holly; Lulla, A.; Xia, T.; Mitra, A.; Harding, T.; Mansoor, A.; Myers, C. L.; Van Ness, B. G.; Dolloff, N. G.

In: Leukemia, Vol. 28, No. 11, 01.11.2014, p. 2263-2267.

Research output: Contribution to journalLetter

Stessman, H, Lulla, A, Xia, T, Mitra, A, Harding, T, Mansoor, A, Myers, CL, Van Ness, BG & Dolloff, NG 2014, 'High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma', Leukemia, vol. 28, no. 11, pp. 2263-2267. https://doi.org/10.1038/leu.2014.214
Stessman, Holly ; Lulla, A. ; Xia, T. ; Mitra, A. ; Harding, T. ; Mansoor, A. ; Myers, C. L. ; Van Ness, B. G. ; Dolloff, N. G. / High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma. In: Leukemia. 2014 ; Vol. 28, No. 11. pp. 2263-2267.
@article{b860eec3f7a942f3b5c522e41240e331,
title = "High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma",
author = "Holly Stessman and A. Lulla and T. Xia and A. Mitra and T. Harding and A. Mansoor and Myers, {C. L.} and {Van Ness}, {B. G.} and Dolloff, {N. G.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1038/leu.2014.214",
language = "English (US)",
volume = "28",
pages = "2263--2267",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma

AU - Stessman, Holly

AU - Lulla, A.

AU - Xia, T.

AU - Mitra, A.

AU - Harding, T.

AU - Mansoor, A.

AU - Myers, C. L.

AU - Van Ness, B. G.

AU - Dolloff, N. G.

PY - 2014/11/1

Y1 - 2014/11/1

UR - http://www.scopus.com/inward/record.url?scp=84922334607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922334607&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.214

DO - 10.1038/leu.2014.214

M3 - Letter

C2 - 25005244

AN - SCOPUS:84922334607

VL - 28

SP - 2263

EP - 2267

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 11

ER -